Company intelligence / Profile preview

MedCana

Colombia

Ownership: Private
Development stage: Other

Overview

MedCana is a commercial-stage holding and operating company developing and supplying pharmaceutical-grade cannabis extracts, using blockchain and agricultural technology to support compliant, traceable medical cannabis production and export, including supply negotiations with an Australian pharmaceutical firm via its Colombian subsidiary.[1][2][3]

Therapeutic areas: Other
Modalities: Plant-derived extractSmall molecule
Industry: Biotech

Partnerships

Prospective supply agreement with an unnamed Australian pharmaceutical firm for medical-grade cannabis through a Colombian subsidiary[2][3]

Beyond the preview

Go deeper on MedCana.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MedCana.

Explore the full profile